As states grapple with tight budgets, rising Medicaid costs and the anticipated expansion of Medicaid following the Supreme Court’s decision to uphold the Patient Protection and Affordable Care Act, policy-makers should consider how community pharmacists can help reduce expenses.
As states grapple with tight budgets, rising Medicaid costs and the anticipated expansion of Medicaid following the Supreme Court's decision to uphold the Patient Protection and Affordable Care Act, policymakers should consider how community pharmacists can help reduce expenses. In addition, new evidence offers a fresh reminder of the perils of managed care in Medicaid and the need for proper oversight of managed care entities.
A few weeks ago, we joined some 37,000 of our closest friends for the Healthcare Information and Management Systems Society (HIMSS) annual conference. HIMSS is a cause-based, not-for-profit organization focused on providing global leadership for the optimal use of information technology (IT) and management systems for the betterment of health care.
Regulators, healthcare providers and the public at large have taken note of the rise in prescription drug substance abuse. A recent article titled "Oxycodone Prescriptions Rose Sharply" in the New York Times (1/11/2012) describes trends of double-digit percentage increases in the dispensing of certain narcotic based painkillers. And many states have, or will be, implementing prescription drug monitoring programs — also known as prescription monitoring programs — that track the physicians prescribing and the patients receiving controlled substances.
The Department of Defense investigation's of a sports supplement ingredient — associated with the death of two soldiers — has been making headlines in the past week as the U.S. Military's independent paper Stars & Stripes ran an update of the news on Jan. 29 and the New York Times picked up on the story Feb. 2.
"I am appalled that politics has once again trumped science," wrote Brooklyn College Health Clinic director and nurse practitioner Ilene Tannenbaum in a letter to the New York Times. That reaction summed up much of the medical community's response to the Department of Health and Human Services' overruling of the Food and Drug Administration's decision to make the Plan B contraceptive pill a full nonprescription product.
Help Remedies, a New York-based creator of "minimalist" over-the-counter medicine, on Tuesday announced national distribution for its line of single-ingredient nonprescription remedies through Walgreens.
Costco Wholesale is calling on the farms that grow cantaloupes and the companies that ship them to be more vigilant in preventing contamination amid one of the deadliest outbreaks of foodborne disease in recent history, according to published reports.
Health experts have expressed fear that Republican presidential candidate Michele Bachmann's comments about the human papillomavirus vaccine could set back progress in vaccinations, according to published reports.
Joseph Selame, who designed a wide range of well-known logos and brand identities for dozens of nonprofit organizations and companies, including CVS/pharmacy, died on March 29 in Boca Raton, Fla. He was 86.
Drug manufacturers are coming up with new versions of their drugs for erectile dysfunction as those drugs’ loss of patent protection and subsequent generic competition draw near, according to published reports.
Walgreens is in the process of introducing a wide-scale national campaign that has its pharmacists recommending Walgreens store-brand products in favor of national brands, the New York Times reported Thursday.